Partner news 17 December 2021 Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform Read full story
2 December 2021 AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform Read full story